High Hematocrit with Normal Hemoglobin: Implications and Management
A high hematocrit with normal hemoglobin most commonly indicates relative polycythemia due to dehydration or stress polycythemia, and management should focus on addressing the underlying cause rather than aggressive phlebotomy, which can lead to iron depletion and increased stroke risk.
Understanding the Discrepancy
When hematocrit is elevated but hemoglobin remains normal, several mechanisms may be responsible:
Technical/Laboratory Factors:
- Sample storage issues: Hematocrit increases by 2-4% when blood samples are stored for prolonged periods, while hemoglobin remains stable 1
- Hyperglycemia: Can falsely elevate MCV and calculated hematocrit without affecting hemoglobin 1
- Analyzer variability: Greater variability exists in hematocrit measurement compared to hemoglobin measurement 1
Clinical Factors:
- Relative polycythemia (pseudopolycythemia): Plasma volume contraction due to dehydration
- Stress polycythemia (Gaisböck syndrome): Characterized by increased hematocrit with normal red cell mass
- Early stage of absolute polycythemia: Before both parameters become elevated
Diagnostic Approach
Rule out technical factors:
- Repeat testing with fresh sample
- Check blood glucose levels
Clinical evaluation:
- Assess hydration status
- Check for symptoms of hyperviscosity (headache, blurred vision, fatigue)
- Evaluate for underlying conditions (smoking, COPD, sleep apnea, heart disease)
Additional testing if clinically indicated:
- Serum erythropoietin (EPO) level: High in secondary polycythemia, low/normal in polycythemia vera 1
- Arterial oxygen saturation to rule out hypoxic causes
- Carboxyhemoglobin levels, especially in smokers
- Red cell mass studies if true polycythemia is suspected
Management Recommendations
For asymptomatic patients with mildly elevated hematocrit:
- Address dehydration if present
- Identify and treat underlying causes (smoking cessation, COPD management, etc.)
- Monitor hematocrit periodically
For symptomatic patients or those with significantly elevated hematocrit (>60%):
- Judicious phlebotomy may be considered to reduce hematocrit to safer levels
- Caution: Aggressive phlebotomy should be avoided due to risk of iron depletion, decreased oxygen-carrying capacity, and stroke 1
Specific management based on underlying cause:
- In chronic obstructive pulmonary disease (COPD): Graded phlebotomy to hematocrit of 55-60% may improve exercise tolerance and cardiac function 1
- In cyanotic heart disease: Avoid aggressive phlebotomy; judicious phlebotomy to hematocrit of 60% may alleviate hyperviscosity symptoms 1
- In post-renal transplant erythrocytosis: Consider ACE inhibitors or angiotensin II receptor blockers 1
Clinical Pitfalls and Caveats
Avoid routine phlebotomies without clear indication as they can lead to iron deficiency, which paradoxically worsens oxygen delivery despite lowering hematocrit 1
Be cautious with testosterone therapy in men, as it commonly causes erythrocytosis, particularly with injectable forms (43.8% of patients may develop hematocrit >52%) 1
Consider the balance between physiological benefit of increased hematocrit and potential impairment of oxygen delivery due to increased blood viscosity 1
Remember that the relationship between hematocrit and hemoglobin is not always a simple 3:1 ratio as commonly assumed, especially in children and with certain conditions 2
Monitor closely in patients with cardiovascular disease, as elevated hematocrit increases blood viscosity and may aggravate vascular disease in coronary, cerebrovascular, or peripheral circulation 1
By understanding the causes of discrepancy between hemoglobin and hematocrit and following a systematic approach to diagnosis and management, clinicians can effectively address this common laboratory finding while avoiding unnecessary interventions that may harm patients.